@prefix pubblicazioni: . @prefix unitaDiPersonaleInterno: . @prefix prodotto: . unitaDiPersonaleInterno:MATRICOLA18686 pubblicazioni:autoreCNRDi prodotto:ID4773 . @prefix prodottidellaricerca: . @prefix istituto: . istituto:CDS059 prodottidellaricerca:prodotto prodotto:ID4773 . @prefix unitaDiPersonaleEsterno: . unitaDiPersonaleEsterno:ID4493 pubblicazioni:autoreCNRDi prodotto:ID4773 . @prefix modulo: . modulo:ID2692 prodottidellaricerca:prodotto prodotto:ID4773 . @prefix rdf: . prodotto:ID4773 rdf:type prodotto:TIPO1101 . @prefix retescientifica: . prodotto:ID4773 rdf:type retescientifica:ProdottoDellaRicerca . @prefix rdfs: . prodotto:ID4773 rdfs:label "Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update (Articolo in rivista)"@en . @prefix xsd: . prodotto:ID4773 pubblicazioni:anno "2008-01-01T00:00:00+01:00"^^xsd:gYear . @prefix skos: . prodotto:ID4773 skos:altLabel "
Brozek J.L.1, Baena-Cagnani C.E.2,3, Bonini S.4,5, Canonica G.W.3, Rasi G.4,6, van Wijk R.G.7, Zuberbier T.8, Guyatt G.9,10, Bousquet J.11, Sch\u00FCnemann H.J.1,8 (2008)
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update
in Allergy (Cph.)
"^^rdf:HTML ; pubblicazioni:autori "Brozek J.L.1, Baena-Cagnani C.E.2,3, Bonini S.4,5, Canonica G.W.3, Rasi G.4,6, van Wijk R.G.7, Zuberbier T.8, Guyatt G.9,10, Bousquet J.11, Sch\u00FCnemann H.J.1,8"^^xsd:string ; pubblicazioni:paginaInizio "38"^^xsd:string ; pubblicazioni:paginaFine "46"^^xsd:string ; pubblicazioni:altreInformazioni "Impact factor = 5.334"^^xsd:string ; pubblicazioni:numeroVolume "63/1"^^xsd:string . @prefix ns12: . prodotto:ID4773 pubblicazioni:rivista ns12:ID309764 ; skos:note "ISI Web of Science (WOS)"^^xsd:string ; pubblicazioni:affiliazioni "1S.C. Epidemiologia, Italian National Cancer Institute \u0092Regina Elena\u0092, Rome, Italy; 2Faculty of Medicine, Catholic University of C\u00F3rdoba, C\u00F3rdoba, Argentina; 3Allergy & Respiratory Diseases, DIMI, Dept. of Internal Medicine, University of Genoa, Genoa, Italy; 4Institute of Neurobiology and Molecular Medicine - CNR, Rome, Italy; 5Department of Medicine, Second University of Naples, Naples, Italy; 6Agenzia Italiana del Farmaco (ALFA), Rome, Italy; 7Section of Allergology, Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands; 8Department of Dermatology and Allergy. Charit\u00E9 Universit\u00E4tsmedizin Berlin, Berlin, Germany; 9CLARITY Research Group, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada; 10Department of Medicine, McMaster University, Hamilton, Canada; 11Clinique des Maladies Respiratoires, CHU Montpellier and INSERM, France\n"^^xsd:string ; pubblicazioni:titolo "Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update"^^xsd:string ; prodottidellaricerca:abstract "BACKGROUND: We describe the methodology for the 2008 update of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. The methodology differs from the 2001 edition in several respects. The most prominent change is the application of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to compiling evidence, assessing the quality of evidence and grading of recommendations. METHODS AND RESULTS: Representatives of the GRADE working group joined the ARIA guideline panel to achieve these tasks. While most recommendations result from existing systematic reviews, systematic reviews were not always available and the panel compiled the best available evidence in evidence profiles without conducting actual reviews. The panel conducted two meetings and used the GRADE criteria to assess the quality of evidence (four categories of high, moderate, low and very low) and the strength of recommendation (strong and weak) based on weighing up the desirable and undesirable effects of management strategies, considering values and preferences influencing recommendations, and resource implications. The guideline panel has chosen the words 'we recommend'--for strong recommendations and 'we suggest'--for weak recommendations. Both categories indicate the best course of action for a given patient population, but their implementation, requires different considerations as we describe subsequently in this article. CONCLUSIONS: The 2008 update of the ARIA guidelines has become more evidence-based. Future iterations of the guidelines will further be improved by following the described processes even closer, such as ensuring availability of updated high quality systematic reviews for each question.\n" ; prodottidellaricerca:prodottoDi istituto:CDS059 , modulo:ID2692 ; pubblicazioni:autoreCNR unitaDiPersonaleInterno:MATRICOLA18686 , unitaDiPersonaleEsterno:ID4493 . @prefix parolechiave: . prodotto:ID4773 parolechiave:insiemeDiParoleChiave . ns12:ID309764 pubblicazioni:rivistaDi prodotto:ID4773 . parolechiave:insiemeDiParoleChiaveDi prodotto:ID4773 .